Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adenocarcinoma × Radiotherapy, Intensity-Modulated × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Nasopharyngeal Carcinoma 26 Squamous Cell Carcinoma of Head and Neck 6 Prostatic Neoplasms 6 Head and Neck Neoplasms 5 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Salivary Gland Neoplasms 2 Neurotoxicity Syndromes 2 Hypopharyngeal Neoplasms 2 Glioblastoma 2 Carcinoma 2 Brain Neoplasms 2 Astrocytoma 2 Vaginal Neoplasms 1 Tongue Neoplasms 1 Thoracic Neoplasms 1 Stage II Prostate Adenocarcinoma AJCC v7 1 Sarcoma 1 Radiation Injuries 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Adenocarcinoma 1 Ototoxicity 1 Oligodendroglioma 1 Obesity 1

Interventions

Oxaliplatin 8 Fluorouracil 6 Docetaxel 6 Paclitaxel 5 Leucovorin 5 Gemcitabine 5 Capecitabine 5 zolbetuximab 4 Cisplatin 4 Ramucirumab 3 Pemetrexed 3 Drug Therapy 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 regorafenib 2 pembrolizumab 2 Vinorelbine 2 Surgical Procedures, Operative 2 Nivolumab 2 Neoadjuvant Therapy 2 Cyclophosphamide 2 Chemoradiotherapy 2 Bevacizumab 2 Afatinib 2 vandetanib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tislelizumab 1 pralsetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03536182 2021-05-26

CIPHER

University of Texas Southwestern Medical Center

Phase 3 Withdrawn

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡